Hepatosplenic T cell lymphoma in inflammatory bowel disease.
Shale
Matthew
M
GI Section, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK.
Kanfer
Ed
E
Panaccione
Remo
R
Ghosh
Subrata
S
D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects*; D007166:Immunosuppressive Agents / Q000009:adverse effects; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D008113:Liver Neoplasms / Q000209:etiology*; D016399:Lymphoma, T-Cell / Q000209:etiology*; D013160:Splenic Neoplasms / Q000209:etiology*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D007155:Immunologic Factors; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha